Recent Finacing
Recent Raise
Scioderm is a clinical-stage pharmaceutical company developing SD-101 (Zorblisa), a topical therapy for epidermolysis bullosa and other chronic skin diseases, advancing US and EU clinical registration programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors